| Dr Roger Jo-chieh Yau, MD | |
|
1450 Matthews Township Pkwy Ste 350, Matthews, NC 28105-2388 | |
| (704) 841-8877 | |
| (704) 841-8188 |
| Full Name | Dr Roger Jo-chieh Yau |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 6 Years |
| Location | 1450 Matthews Township Pkwy Ste 350, Matthews, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780021600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 201901499 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Matthews Medical Center | Matthews, NC | Hospital |
| Novant Health Presbyterian Medical Center | Charlotte, NC | Hospital |
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Novant Health Mint Hill Medical Center | Charlotte, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Specialists Of The Carolinas Pllc | 0648178020 | 38 |
| Stone Institute Of The Carolinas Llc | 3173412533 | 32 |
News Archive
"We eat first with our eyes." This comment has been attributed to Marcus Gavius Apicius, a 1st Century Roman gourmand. Two thousand years later, academic research backs up Apicius' statement, as a team of marketing professors at the Fowler College of Business at San Diego State University have studied the sensory impact of food and the evolution of healthy eating.
House Oversight and Government Reform Committee Chairman Darrell Issa, R-Calif., has raised questions about the implementation of a key part of the health law - the tax treatment of subsidies for low-income people to purchase health insurance.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.
Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.
› Verified 2 days ago
| Entity Name | Urology Specialists Of The Carolinas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669404208 PECOS PAC ID: 0648178020 Enrollment ID: O20040127000244 |
News Archive
"We eat first with our eyes." This comment has been attributed to Marcus Gavius Apicius, a 1st Century Roman gourmand. Two thousand years later, academic research backs up Apicius' statement, as a team of marketing professors at the Fowler College of Business at San Diego State University have studied the sensory impact of food and the evolution of healthy eating.
House Oversight and Government Reform Committee Chairman Darrell Issa, R-Calif., has raised questions about the implementation of a key part of the health law - the tax treatment of subsidies for low-income people to purchase health insurance.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.
Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.
› Verified 2 days ago
| Entity Name | Stone Institute Of The Carolinas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457377954 PECOS PAC ID: 3173412533 Enrollment ID: O20040312001126 |
News Archive
"We eat first with our eyes." This comment has been attributed to Marcus Gavius Apicius, a 1st Century Roman gourmand. Two thousand years later, academic research backs up Apicius' statement, as a team of marketing professors at the Fowler College of Business at San Diego State University have studied the sensory impact of food and the evolution of healthy eating.
House Oversight and Government Reform Committee Chairman Darrell Issa, R-Calif., has raised questions about the implementation of a key part of the health law - the tax treatment of subsidies for low-income people to purchase health insurance.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.
Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roger Jo-chieh Yau, MD 1450 Matthews Township Pkwy Ste 350, Matthews, NC 28105-2388 Ph: (704) 841-8877 | Dr Roger Jo-chieh Yau, MD 1450 Matthews Township Pkwy Ste 350, Matthews, NC 28105-2388 Ph: (704) 841-8877 |
News Archive
"We eat first with our eyes." This comment has been attributed to Marcus Gavius Apicius, a 1st Century Roman gourmand. Two thousand years later, academic research backs up Apicius' statement, as a team of marketing professors at the Fowler College of Business at San Diego State University have studied the sensory impact of food and the evolution of healthy eating.
House Oversight and Government Reform Committee Chairman Darrell Issa, R-Calif., has raised questions about the implementation of a key part of the health law - the tax treatment of subsidies for low-income people to purchase health insurance.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
The Global Alliance for TB Drug Development (TB Alliance), a non-profit public-private partnership developing affordable, new drug regimens for tuberculosis, today announced the start of Phase I clinical trials for the lead TB drug in its pipeline, PA-824. The trials begin this month.
Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.
› Verified 2 days ago
Samuel Stuart Dupuy Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1450 Matthews Township Parkway, Matthews, NC 28105 Phone: 704-846-0809 Fax: 704-283-4705 | |
Dr. Bradley Kent Weisner, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1450 Matthews Township Pkwy, Suite 350, Matthews, NC 28105 Phone: 704-841-8877 Fax: 704-841-8188 | |
Liliya Petrovna Velet, MD Urology Medicare: Medicare Enrolled Practice Location: 1450 Matthews Township Pkwy Ste 350, Matthews, NC 28105 Phone: 704-841-8877 Fax: 704-841-8188 | |
Dr. Thomas Hogeman Phillips, MD Urology Medicare: Medicare Enrolled Practice Location: 1450 Matthews Township Pkwy, Suite 350, Matthews, NC 28105 Phone: 704-841-8877 Fax: 704-841-8188 |